Marcos, Jayden Carl .
HRN: 24-76-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2024
MUPIROCIN 2%, 15G (TUBE)
12/25/2024
12/31/2024
TOPICAL
Thin Layer
TID
IV Site Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes